companydata.dkSerprozyme ApS: Financial statements 2024
CVR: 44083205
Serprozyme ApS (CVR 44083205) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 31,033 and a net result of DKK 24,507. Equity amounted to DKK 62,321. The solvency ratio was 90.1%.
- Gross Profit
- 31,033 kr.
- Profit/Loss
- 24,507 kr.
- Equity
- 62,321 kr.
- Total Assets
- 69,141 kr.
- Employees
- 0
How creditworthy is Serprozyme ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Serprozyme ApS has published its interim report for the period May 26, 2023 – December 31, 2023.
About Serprozyme ApS
Serprozyme ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kristian Jensen. The company is owned by Emvijo Initiative ApS and Jan Kristian Jensen Holding ApS. In 2025, the company reported a gross profit of DKK 168,506 and a net result of DKK 131,445 compared with DKK 24,507 the year before. Equity amounted to DKK 193,766.